Investing in Carlisle Companies Incorporated (CSL)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)43.57-88
Intrinsic value (DCF)75.04-80
Graham-Dodd Method83.84-78
Graham Formula0.00-100

Company description

CSL, or Commonwealth Serum Laboratories, is a global biopharmaceutical company headquartered in Melbourne, Australia. Founded in 1916, CSL has grown into one of the world's largest and most advanced manufacturers of plasma protein and influenza vaccines. The company operates in over 30 countries and employs more than 27,000 people. CSL has a strong commitment to research and development, investing heavily in innovation and cutting-edge technology to drive advancements in the medical industry. In addition to its focus on vaccines and plasma therapies, CSL also has a growing presence in specialty and rare diseases. The company is dedicated to safeguarding public health and has a history of rapid response to emerging health threats, such as the recent COVID-19 pandemic. CSL's mission is to improve the quality of life for patients around the world by providing innovative and life-saving treatments, and its strong financial performance and consistent growth demonstrate its success in achieving this goal. With a strong focus on sustainability and corporate responsibility, CSL continues to be a leading force in the biopharmaceutical industry, driven by its commitment to making a positive impact on global health.